AUTM Speaks Out

Taking a Stand

Read the letters and papers that AUTM has authored or signed.

2018

World Intellectual Property Organization (WIPO)
AUTM joined a coalition of organizations in a letter to Secretary of State Mike Pompeo. The group urged continued U.S. leadership and engagement in WIPO — such engagement is a critical component of U.S. efforts to promote and protect American innovation around the world.

2018

 

SUCCESS Act
AUTM joined other higher ed organizations in a statement of support for the Study of Underrepresented Classes Chasing Engineering and Science Success (SUCCESS) Act and efforts to foster greater diversity and inclusion within the innovation ecosystem.

2018

NIST ROI  Statement
AUTM issued a response to the National Institute of Standards & Technology (NIST), which is assessing the Federal technology transfer system and soliciting feedback.

2018

PTAB Claim Constuction
AUTM issued comments on the USPTO’s proposed changes to the Claim Construction Standard used in PTAB Proceedings.

2018

Bayh-Dole Rule Changes: What They are, What They Mean
AUTM hosted a free webinar to discuss the changes. View the webinar

2017

AUTM-BIO Report
The licensing of university research has made a significant contribution to US gross domestic product (GDP), industry gross output, and jobs over the last two decades, according to an independent study commissioned by AUTM and the Biotechnology Innovation Organization (BIO). Read it here

2017

STRONGER Patents Act
AUTM joined the Association of American Universities (AAU), Association of Public and Land-grant Universities (APLU) and Council on Governmental Relations (COGR) to release a joint statement regarding the introduction of the Support Technology and Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act in the U.S. Senate.

2017

Letter to the FDA
AUTM joined the Association of American Medical Colleges (AAMC), Association of American Universities (AAU), Association of Public Land-grant Universities (APLU) and the Council On Governmental Relations (COGR) in a letter to Dr. Scott Gottlieb, Comissioner of Food and Drugs at the U.S. Food and Drug Administration. Read the letter

2017

 

World Intellectural Property Organizaton (WIPO)
AUTM joined other organizations in letter to Secretary Tillerson to emphasize the importance of continued U .S. engagement in the WIPO as a critical component of U.S. efforts to provide effective protection and enforcement of U. S. intellectual property rights, a core component of the Administration’s trade policy agenda.

2016

Federally Funded Inventions
AUTM  joined other organiztions to comment on the Rights to Federally Funded Inventions and Licensing of Government Owned Inventions.

2015

Patient Advocacy Groups Concerned About H.R. 9
More than 100 patient advocacy groups sent a joint letter to House and Senate leaders to express concerns that H.R. 9, the "Innovation Act" falls short of preserving important patent protections for biopharmaceutical innovation. Read more.

2015

Senate Testimony on Patent Reform
David Winwood, AUTM’s then President-Elect, testified before the U.S. Senate Committee on Small Business and Entrepreneurship about the importance of maintaining a fair and equitable U.S. patent system from the perspective of U.S. research universities. His testimony  took place during a hearing titled, “Patent Reform: Protecting Innovation and Entrepreneurship.”  Read testimonial.

2014

AUTM Participates in Capitol Hill Briefing on Tech Transfer Policy
The Congressional Technology Transfer Caucus conducted a Capitol Hill briefing on technology transfer policy reform on January 28. A panel of national experts discussed university R&D commercialization issues as well as proposed policy solutions to accelerate research into the marketplace. Click here to view a video from the briefing.